Discover
PTHS
Pelthos Therapeutics Inc.
20.50
900 x 15.37
200 x 26.00
bid
ask
+
0.00
0.00%
550 @ 04:00 PM
20.50 +0.00 (0.00%)
| Ytd | -33.87% | |
| 1y | -18.00% |
20.50
day range
21.15
18.19
52 week range
37.42
| Open | 20.80 | Prev Close | 20.50 | Low | 20.50 | High | 21.15 | Mkt Cap | 78.48M |
| Vol | 45.02K | Avg Vol | 60.07K | EPS | -27.53 | P/E | N/A | Forward P/E | N/A |
| Beta | 3.07 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 24.44 | 200-d Avg | 24.91 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 15.60M | ||
| Revenues (USD) | 15.60M | ||
| Cost of Revenue | 3.61M | ||
| Gross Profit | 11.99M | ||
| Operating Expenses | 29.32M | ||
| Research and Development Expense | 600.00K | ||
| Selling, General and Administrative Expense | 27.67M | ||
| Operating Income | -17.32M | ||
| Interest Expense | 2.39M | ||
| Net Income | -23.42M | ||
| Net Income Common Stock | -23.42M | ||
| Net Income Common Stock (USD) | -23.42M | ||
| Consolidated Income | -23.42M | ||
| Earnings per Basic Share | -6.62 | ||
| Earnings per Basic Share (USD) | -6.62 | ||
| Earnings per Diluted Share | -6.62 | ||
| Earning Before Interest & Taxes (EBIT) | -21.03M | ||
| Earning Before Interest & Taxes (USD) | -21.03M | ||
| Weighted Average Shares | 3.54M | ||
| Weighted Average Shares Diluted | 3.54M | ||
| Balance Sheet | |||
| Cash and Equivalents | 24.56M | ||
| Cash and Equivalents (USD) | 24.56M | ||
| Trade and Non-Trade Receivables | 14.48M | ||
| Current Assets | 63.36M | ||
| Property, Plant & Equipment Net | 11.92M | ||
| Total Assets | 137.36M | ||
| Debt Current | 645.00K | ||
| Total Debt | 73.11M | ||
| Current Liabilities | 31.96M | ||
| Debt Non-Current | 72.46M | ||
| Total Liabilities | 138.86M | ||
| Accumulated Retained Earnings (Deficit) | -113.28M | ||
| Accumulated Other Comprehensive Income | 2.08M | ||
| Shareholders Equity | -1.50M | ||
| Shareholders Equity (USD) | -1.50M | ||
| Assets Non-Current | 74.00M | ||
| Total Debt (USD) | 73.11M | ||
| Deferred Revenue | 1.82M | ||
| Goodwill and Intangible Assets | 62.08M | ||
| Inventory | 21.47M | ||
| Liabilities Non-Current | 106.90M | ||
| Trade and Non-Trade Payables | 5.85M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.39M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.67M | ||
| Capital Expenditure | -2.00K | ||
| Net Cash Flow from Investing | -2.00K | ||
| Net Cash Flow from Operations | -7.66M | ||
| Share Based Compensation | 2.76M | ||